Dechra Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Dechra Pharmaceuticals has a total shareholder equity of £841.7M and total debt of £520.1M, which brings its debt-to-equity ratio to 61.8%. Its total assets and total liabilities are £1.7B and £902.6M respectively. Dechra Pharmaceuticals's EBIT is £85.3M making its interest coverage ratio 6.4. It has cash and short-term investments of £87.9M.
Key information
61.8%
Debt to equity ratio
UK£520.10m
Debt
| Interest coverage ratio | 6.4x |
| Cash | UK£87.90m |
| Equity | UK£841.70m |
| Total liabilities | UK£902.60m |
| Total assets | UK£1.74b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DPH N's short term assets (£459.3M) exceed its short term liabilities (£168.4M).
Long Term Liabilities: DPH N's short term assets (£459.3M) do not cover its long term liabilities (£734.2M).
Debt to Equity History and Analysis
Debt Level: DPH N's net debt to equity ratio (51.3%) is considered high.
Reducing Debt: DPH N's debt to equity ratio has increased from 55.4% to 61.8% over the past 5 years.
Debt Coverage: DPH N's debt is not well covered by operating cash flow (16.6%).
Interest Coverage: DPH N's interest payments on its debt are well covered by EBIT (6.4x coverage).